FiscalNote Announces New Strategic Partnership with Creolytix,[...]
NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical[...]
05/09/2024 | Press release | Distributed by Public on 05/09/2024 15:31
Please select the service you want to use:
Smartlinks | Phio Pharmaceuticals Corp. | News | Health | Science | Biology | Local News | Company News | Top Company News | Business Announcement | Pharmaceuticals | Securities Issuers | Biotechnology and Medical Research Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact